Patients' Attitudes Towards Open-Label Placebo Implementation Into Clinical Practice
Patients' Attitudes Towards Open-Label Placebo Implementation Into Clinical Practice
The aim of this project is to assess patients' opinions, attitudes, and ideas regarding the administration of OLPs in clinical practice, although they might never have had contact to placebos. A qualitative approach is used and online focus group discussions (FGD) with patients with different clinical conditions, entailing chronic back pain, Parkinson's disease, chronic migraine, chemotherapy induced emesis, and menopausal complaints are conducted.
Substantial placebo effects have been known for several decades for a multitude of physical as well as psychological complaints. It is essential to test the acceptability of Open-label placebos (OLPs) of patients and health professionals. The aim of this project is to assess patients' opinions, attitudes, and ideas regarding the administration of OLPs in clinical practice, although they might never have had contact to placebos. A qualitative approach is used and online focus group discussions (FGD) with patients with different clinical conditions, entailing chronic back pain, Parkinson's disease, chronic migraine, chemotherapy induced emesis, and menopausal complaints are conducted. A semi-structured topic guide with open-ended questions will be used.
Inclusion Criteria:
Signed informed Consent form (see Appendix)
Capable of consent (language/cognitive)
At least 18 years of age
Ability to attend an online conference in regard of physical and psychological condition and technical knowhow and equipment
In addition, participants have to be affected by one of the following conditions/disorders:
Exclusion Criteria: